Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07357935 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Early Inflammatory-Immune Stratification and Precision Glucocorticoid Intervention in Acute Respiratory Failure Induced by Community-Acquired Pneumonia

StatusNot Yet Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a prospective, multicenter, interventional cohort study aimed at constructing a high-quality, dynamic multimodal database for patients with acute respiratory failure caused by community-acquired pneumonia (CAP-ARF). The study focuses on bacterial CAP-ARF patients receiving standardized glucocorticoid therapy to investigate the heterogeneity of treatment responses under different etiologies and immune statuses. The goal is to provide a data foundation for precise immune stratification and identification of glucocorticoid-sensitive populations.
Trial Details
NCT Number NCT07357935
Lead Sponsor Qingyuan Zhan
Collaborators: The First Affiliated Hospital of Guangzhou Medical University, Wuhan Metware Biotechnology Co., Ltd.
Conditions
(from sponsor)		 Acute Respiratory Failure, Community-Acquired Pneumonia
Related terms Community-Acquired Pneumonia
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov